Physician profile
Jyoti Yeli
NPI 1457596165
$5,416.15
in general payments reported to CMS, 2019-2025
31 companies · $808 in 2025
The $808 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $282 · 2021: $499 · 2022: $892 · 2023: $1,240 · 2024: $1,327 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,374.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $684.97 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $643.06 | 2019-2025 | |
| Glaxosmithkline, LLC. | $614.39 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $583.40 | 2022-2025 | |
| Novo Nordisk INC | $569.05 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $396.42 | 2019-2025 | Repatha, Otezla, Prolia |
| Novartis Pharmaceuticals Corporation | $360.08 | 2022-2025 | |
| Exact Sciences Corporation | $263.17 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $244.16 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $203.46 | 2021-2025 | Vraylar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.81 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.25 | 2022-2025 | Xifaxan |
| Daiichi Sankyo INC. | $93.44 | 2022-2025 | Injectafer |
| Corcept Therapeutics | $70.08 | 2025 | Korlym |
| Merck Sharp & Dohme LLC | $64.77 | 2020-2025 | Verquvo, Belsomra, Lagevrio |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $44.60 | 2025 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $38.52 | 2021-2025 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $38.07 | 2023 | Quviviq |
| Philips North America LLC | $36.52 | 2024 | (Ck7) Extended Holter |
| Bausch Health US, LLC | $35.64 | 2022-2023 | Wellbutrin, Aplenzin |
| Biohaven Pharmaceuticals, INC. | $25.85 | 2021 | |
| Astellas Pharma US INC | $24.05 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.06 | 2023 | Vpriv |
| Biohaven Pharmaceutical Holding Company LTD. | $22.10 | 2022 | |
| Vertos Medical, INC. | $20.61 | 2024 | Mild Device Kit |
| Amarin Pharma, INC. | $17.53 | 2021 | |
| Phathom Pharmaceuticals, INC. | $17.46 | 2024 | Voquezna |
| Nevro Corp. | $16.07 | 2023 | Senza |
| E.R. Squibb & Sons, L.L.C. | $13.31 | 2023 | Eliquis |
| Allergan, INC. | $11.25 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jyoti Yeli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.